Business Standard

Mutual funds' October report: Financial stocks out, pharmaceuticals in

The sector remains underweight on banking and financial stocks, reducing positions in HDFC Bank (Rs 1,073 crore), HDFC Ltd (Rs 895 crore), and Axis Bank (Rs 647 crore)

equity, mf, mutual funds, cash, outflow, stocks, shares, investment
Premium

Fund houses added pharma counters such as Dr Reddy’s (Rs 750 crore), Sun Pharma (Rs 300 crore), Lupin (Rs 137 crore), and Apollo Hospital (Rs 100 crore), with some profit-booking seen in IPCA Labs (Rs 190 crore)

Ashley Coutinho Mumbai
The top additions for MFs in October were Dr Reddy’s, D Mart, and Bharti Airtel. At the same time, Infosys, HUL, and HDFC Bank were major reductions in portfolios.

The sector remains underweight on banking and financial stocks, reducing positions in HDFC Bank (Rs 1,073 crore), HDFC Ltd (Rs 895 crore), and Axis Bank (Rs 647 crore), while minor additions were also seen in SBI (Rs 200 crore) and Kotak Mahindra Bank (Rs 133 crore). Banking and financial stocks have run up this month, with the NSE Bankex up 9.5 per cent.

Funds trimmed positions in FMCG stocks, too, such as Hindustan

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 12 2020 | 11:36 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com